Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen|DRUG: Placebo capsules, Letrozole, Anastrozole, Tamoxifen
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.